Abstract:10644 Background: To evaluate the correlations of clinical pathologic status, expression of tumor markers and prognosis in 5000 Chinese breast cancer. Methods: A series primary operable breast cancers from 2002 to 2005 were studied in Tianjin Cancer Hospital. 55% of them are premenopausal and median age is 45 years old; 45% of them are postmenopausal and median age is 58 years old. All of the cases were reviewed by pathologist. ER, PgR, HER-2, p53, PCNA were measured by imunohistochemistry (IHC). Recurrence or metastasis were seen in 126 cases (median follow-up 30 months). Results: Negative axillary lymph nodes in 49.8%,and nodes positive in 50.2% (1 to 3 nodes positive in 28.3%, 4 to 9 nodes positive in 12.1% and over 10 nodes positive in 9.8%). Hermone receptor were observed in 51.7% ER+, 44.7% PgR+, 36.2% ER+/PgR+, 15.5% ER+/PgR−, 8.5% ER−/PgR+, 39.8% ER−/PgR−. HER-2 were observed in 56.8% her-2(-) ,21.7% her-2(+), 10.4% her-2(++) and 11.1% her-2(+++). p53 were observed in 34.4% (+) and PCNA were observed in 85.9% (+). Conclusions: First, Her-2 expression is shown positive correlation with positive axillary lymph nodes, especially remarkable correlated in the number of positive nodes in premenopausal patients. Second, Her-2 expression is shown negative correlation with ER and PgR. Third, Her-2 expression has no correlation with histologic grades of tumors and in some conditions has positive correlation with p53 and PCNA. Fifth, Her-2 expression has no correlation with recurrence, but positive correlation with distant metastasis. In general, Her-2 expression in breast cancer could be taken as the independent index for predicting prognosis. Status of axillary lymph nodes, expression of ER, PgR are the independent factor for expression of her-2. Expression of p53 and PCNA couldn’t be taken as the independent index for predict prognosis. No significant financial relationships to disclose.

Clinical Biology Value of P53 Overexpression in Chinese Breast Cancer by Meta Analysis

Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer]

Expression and Significance of P51 Gene in Breast Cancer

P53 Protein Expression Levels in Stage I Breast Cancer and Its Relationship to Clinico - Pathologic Parameters

Overexpression of P53 is prognostic for aromatase inhibitor resistance in early stage postmenopausal patients with ER-positive breast cancer

[Peripheral Blood Mutated P53 DNA and Its Clinical Value in Human Breast Cancer].

Clinical Value of P_53 Gene Mutation in Bladder Cancer

Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

p53 mutation in plasma DNA and its prognostic value in breast cancer patients.

Clinical Pathologic Status and Expression of Tumor Markers in 5,000 Chinese Breast Cancers

Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression

Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients.

Mutagen Sensitivity and P53 Expression in Colorectal Cancer in China.

[P53 Expression and Its Clinical Significance in Prostatic Carcinoma].

Analysis of the relationship between p53 gene mutation and clinical pathophysiological characteristics of primary non-small cell lung cancer

P53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette-Guérin: a Meta-Analysis.

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA

P53 Status As a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer

Prevalence and Clinical Impact of TP53 Germline Mutations in Chinese Women with Breast Cancer

Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma

Retracted: P53 Mutation in Plasma Dna and Its Prognostic Value in Breast Cancer Patients (retracted Article. See Vol 8, Pg 3027, 2002)